Atamyo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Atamyo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Atamyo Today - Breaking & Trending Today

Atamyo Therapeutics Announces First Patient Dosed with ATA-100 Gene Therapy in LGMD-R9 Clinical Trial

First patient dosed with ATA-100 gene replacement therapy for LGMD-R9 On-going multicenter, Phase 1/2 study evaluating safety, pharmacodynamic and efficacy of ATA-100 Atamyo Therapeutics ....

United States , France General , United Kingdom , Kostenloser Wertpapierhandel , Stephane Degove , John Vissing , Charles Craig , Sophie Olivier , Isabelle Richard , Copenhagen Neuromuscular Center , Progressive Muscular Dystrophies Laboratory At Genethon , Drug Administration , European Medicines Agency , Opus Biotech Communications , National Hospital , Chief Executive Officer , Adeno Associated Virus , Chief Medical Officer , Progressive Muscular Dystrophies Laboratory , Orphan Drug Designation , European Medicines , Celtic Atao ,

Atamyo Therapeutics Reaches Significant Regulatory and Financial Milestones for ATA-100, its Gene Therapy to Treat Limb-Girdle Muscular Dystrophy Type 2I/R9

Additional approval of Clinical Trial Application received from Denmark Danish Medicines Agency (DKMA) Orphan Drug Designation awarded from US FDA and European EMA Non-dilutive public ....

United States , United Kingdom , Kostenloser Wertpapierhandel , Charles Craig , Isabelle Richard , Deeptech Development Aid , Drug Administration , Regulatory Agency , Denmark Danish Medicines Agency , Progressive Muscular Dystrophies Laboratory At Genethon , Opus Biotech Communications , European Medicines Agency , Denmark Medicines Agency , Clinical Trial Application , Drug Designation , United Kingdom Medicines Healthcare , Orphan Drug Designation , Drug Designations , Atamyo Chief Scientific Officer Isabelle Richard , Research Director , Progressive Muscular Dystrophies Laboratory , Celtic Atao ,

Atamyo Therapeutics Reaches Significant Regulatory and Financial Milestones for ATA-100, its Gene Therapy to Treat Limb-Girdle Muscular Dystrophy Type 2I/R9

Additional approval of Clinical Trial Application received from Denmark Danish Medicines Agency (DKMA) Orphan Drug Designation awarded from US FDA and European EMA Non-dilutive public ....

United States , United Kingdom , Kostenloser Wertpapierhandel , Charles Craig , Isabelle Richard , Deeptech Development Aid , Drug Administration , Regulatory Agency , Denmark Danish Medicines Agency , Progressive Muscular Dystrophies Laboratory At Genethon , Opus Biotech Communications , European Medicines Agency , Denmark Medicines Agency , Clinical Trial Application , Drug Designation , United Kingdom Medicines Healthcare , Orphan Drug Designation , Drug Designations , Atamyo Chief Scientific Officer Isabelle Richard , Research Director , Progressive Muscular Dystrophies Laboratory , Celtic Atao ,

Atamyo Therapeutics Submits CTA in Europe for ATA-100, Its Gene Therapy to Treat Limb-Girdle Muscular Dystrophy Type 2I/R9

Company also appoints Sophie Olivier, M.D., Chief Medical Officer, joining co-founders Stephane Degove, Chief Executive Officer, and Isabelle Richard, Ph.D., Chief Scientific Officer Atamyo is a ....

City Of , United Kingdom , Kostenloser Wertpapierhandel , Stephane Degove , Charles Craig , Sophie Olivier , Isabelle Richard , Pediatric Team , Progressive Muscular Dystrophies Laboratory At Genethon , European Medicines Agency , Women Health , Opus Biotech Communications , Chief Medical Officer , Chief Executive Officer , Chief Scientific , Clinical Trial Application , Chief Scientific Officer , Paris Based Genethon , Atamyo Chief Scientific Officer Isabelle Richard , Research Director , Progressive Muscular Dystrophies Laboratory , Scientific Officer , Wyeth Pharmaceutical , Celtic Atao ,